Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. Edurant / Truvada
2. Emtricitabine / Rilpivirine /tenofovir Disoproxil
3. Emtricitabine Mixture With Rilpivirine Hydrochloride And Tenofovir Disoproxil Fumarate
4. 847446-10-0
Molecular Weight | 1285.6 g/mol |
---|---|
Molecular Formula | C53H63ClFN14O17PS |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 29 |
Rotatable Bond Count | 26 |
Exact Mass | 1284.3626506 g/mol |
Monoisotopic Mass | 1284.3626506 g/mol |
Topological Polar Surface Area | 471 Ų |
Heavy Atom Count | 88 |
Formal Charge | 0 |
Complexity | 1800 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
1 of 2 | |
---|---|
Drug Name | Complera |
PubMed Health | Emtricitabine/Rilpivirine/Tenofovir (By mouth) |
Drug Classes | Antiretroviral Agent |
Drug Label | COMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine hydrochloride, and tenofovir DF. EMTRIVA is the brand name for emtricitabine, a synthetic nucleoside analog of cytidine. EDURANT is the brand name for rilpivirine, a no... |
Active Ingredient | tenofovir disoproxil fumarate; rilpivirine hydrochloride; Emtricitabine |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 200mg; eq 25mg base |
Market Status | Prescription |
Company | Gilead Sciences |
2 of 2 | |
---|---|
Drug Name | Complera |
PubMed Health | Emtricitabine/Rilpivirine/Tenofovir (By mouth) |
Drug Classes | Antiretroviral Agent |
Drug Label | COMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine hydrochloride, and tenofovir DF. EMTRIVA is the brand name for emtricitabine, a synthetic nucleoside analog of cytidine. EDURANT is the brand name for rilpivirine, a no... |
Active Ingredient | tenofovir disoproxil fumarate; rilpivirine hydrochloride; Emtricitabine |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 200mg; eq 25mg base |
Market Status | Prescription |
Company | Gilead Sciences |
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?